We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
Cap. Flow
-$307M
Cap. Flow %
-4.25%
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679

Sector Composition

Rank Sector Weight
1 Financials 12.25%
2 Industrials 9.66%
3 Utilities 9.48%
4 Technology 8.06%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUP
1851
DELISTED
Tupperware Brands Corporation
TUP
$39.9K ﹤0.01%
+15,965
New +$58.9K
RRAC.WS
1852
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$39.8K ﹤0.01%
301,700
SVIIR
1853
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$39K ﹤0.01%
195,000
-5,000
-3% -$948
GROY icon
1854
Gold Royalty Corp
GROY
$621M
$38.8K ﹤0.01%
+17,970
New +$41.2K
SOAR.WS
1855
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$36.5K ﹤0.01%
472,771
FULC icon
1856
Fulcrum Therapeutics
FULC
$290M
$33.5K ﹤0.01%
+11,772
New +$105K
BVS icon
1857
Bioventus
BVS
$909M
$32.9K ﹤0.01%
30,770
+11,814
+62% +$22.6K
AMRX icon
1858
Amneal Pharmaceuticals
AMRX
$5.9B
$32.2K ﹤0.01%
23,154
+11,554
+100% +$23K
IVCBW
1859
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$32.1K ﹤0.01%
321,140
CCCC icon
1860
C4 Therapeutics
CCCC
$399M
$32K ﹤0.01%
+10,188
New +$60K
STET.WS
1861
DELISTED
ST Energy Transition I Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50, included as part of the SAIL securities
STET.WS
$31.7K ﹤0.01%
186,750
SCRMW
1862
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$30.6K ﹤0.01%
145,833
ATAKR
1863
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$30.1K ﹤0.01%
200,711
NEGG icon
1864
Newegg Commerce
NEGG
$321M
$29.9K ﹤0.01%
+1,115
New +$34.8K
BBD icon
1865
CALL
Banco Bradesco
BBD
$37.9B
$29.9K ﹤0.01%
11,400
-70,180
-86% -$187K
ASCBR
1866
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$29.3K ﹤0.01%
300,000
HCVIW
1867
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$28.7K ﹤0.01%
179,406
BHACW
1868
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$28.6K ﹤0.01%
237,846
TLS icon
1869
Telos
TLS
$365M
$27.9K ﹤0.01%
+11,031
New +$45K
LEV
1870
DELISTED
The Lion Electric Company
LEV
$27.5K ﹤0.01%
+14,797
New +$33.4K
CVM icon
1871
CEL-SCI Corp
CVM
$23.8M
$26.9K ﹤0.01%
387
+50
+15% +$3.91K
IBRX icon
1872
ImmunityBio
IBRX
$7.28B
$24.8K ﹤0.01%
+13,625
New +$42.4K
ISRLW
1873
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$24.1K ﹤0.01%
+172,153
New +$23.2K
FSP
1874
Franklin Street Properties
FSP
$48.4M
$23.7K ﹤0.01%
+15,100
New +$37.9K
DMYY.WS
1875
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
$23.4K ﹤0.01%
75,546
-2,206
-3% -$729

Similar funds

Verition Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.

  • Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
  • Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
  • Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
  • Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
  • Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
  • Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
  • Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.